EUVIMEDEUVIMED entdecken
Crossref

Benchmarking heart failure care: the ANZACS-QI Heart Failure Registry Pilot implementation and results (ANZACS-QI 86)

Aleisha Easton, Andrew Kerr, Susan Wells, Robert Doughty, Andy McLachlan, Mary Morgan, Ursula Balzat, Heather Brannigan, Sarah Adkin, Mayanna Lund, Katrina Poppe, Matire Harwood und 4 weitere

New Zealand Medical Journal · 20.11.2026 · 139 (1646) · 25-38

DOI: 10.26635/6965.7408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Zealand Medical Journal, online erschienen am 20.11.2026. Verfasst von Aleisha Easton und 15 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

aims: Heart failure is a major healthcare problem in Aotearoa New Zealand. As therapies advance and become increasingly complex it is essential that we systematically characterise phenotype and monitor adherence to relevant guidelines to drive quality improvement. Here we report the results of the ANZACS-QI Heart Failure Registry Pilot, implemented in Northern Region hospitals. methods: Age-stratified random sampling was used to identify a representative cohort of patients hospitalised with heart failure (2022 and 2023) using national administrative datasets. The electronic clinical records were reviewed and data entered into the web-based registry. Pre-specified outcomes that were analysed included rates of left ventricular assessment (left ventricular ejection fraction [LVEF]) and prescription of guideline-directed medical therapy (GDMT). results: The cohort comprised 328 patients and registry form completion rates were high (98%). LVEF assessment rates within 2 years of the index hospital discharge were 81%. Of those with heart failure with reduced ejection fraction that survived until discharge (n=137), only 13 (9%) met the composite medication indicator of being prescribed (or with documented contraindication/intolerance) all four GDMT classes. This was largely driven by 92 (67%) being ineligible for subsidy for sodium glucose co-transporter-2 inhibitors; however, prescription rates of the other GDMT classes were suboptimal. conclusions: Our study highlights that there is a considerable gap between guideline recommendations and real-world practice. Following pilot completion, performance indicators have been established and the registry has expanded with the goal for it to become national. The successful implementation of the registry is an important step in quality improvement for patients hospitalised with heart failure.

Zitieren

APA

Easton, A., Kerr, A., Wells, S., Doughty, R., McLachlan, A., Morgan, M., Balzat, U., Brannigan, H., Adkin, S., Lund, M., Poppe, K., Harwood, M., Grey, C., Selak, V., Harrison, W., & Chan, D. (2026). Benchmarking heart failure care: the ANZACS-QI Heart Failure Registry Pilot implementation and results (ANZACS-QI 86). New Zealand Medical Journal, 139(1646), 25-38. https://doi.org/10.26635/6965.7408

Vancouver

Easton A, Kerr A, Wells S, Doughty R, McLachlan A, Morgan M, et al. Benchmarking heart failure care: the ANZACS-QI Heart Failure Registry Pilot implementation and results (ANZACS-QI 86). New Zealand Medical Journal. 2026;139(1646):25-38. doi:10.26635/6965.7408

BibTeX
@article{Easton2026,
  author = {Easton, Aleisha and Kerr, Andrew and Wells, Susan and Doughty, Robert and McLachlan, Andy and Morgan, Mary and Balzat, Ursula and Brannigan, Heather and Adkin, Sarah and Lund, Mayanna and Poppe, Katrina and Harwood, Matire and Grey, Corina and Selak, Vanessa and Harrison, Wil and Chan, Daniel},
  title = {Benchmarking heart failure care: the ANZACS-QI Heart Failure Registry Pilot implementation and results (ANZACS-QI 86)},
  journal = {New Zealand Medical Journal},
  year = {2026},
  volume = {139},
  number = {1646},
  pages = {25--38},
  doi = {10.26635/6965.7408}
}
Kostenlos starten →